NRO position on provision of COVID-19 vaccine to patients with End Stage Kidney Disease

NRO position on provision of COVID-19 vaccine to patients with End Stage Kidney Disease

The National Renal Office (NRO) endorses the position taken by other International Nephrology
Societies/patient groups regarding the provision of the COVID 19 vaccine for “extremely vulnerable”
patients with End Stage Kidney Disease, (patients on renal dialysis, patients waiting to start dialysis
and patients who have received a kidney transplant).

Click here to view full NRO statement.

 

Click here to view UK Renal Community Position Statement.

Leave a Reply

Close Menu
×
×

Basket